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Abstract
Purpose Cigarettes have been demonstrated to be toxic to the pulmonary connective tissue by impairing the lung’s ability 
to clear debris, resulting in infection and acute respiratory distress syndrome (ARDS). Approximately 8% of adolescents are 
smokers. We hypothesized that adolescent trauma patients who smoke have a higher rate of ARDS and pneumonia when 
compared to non-smokers.
Methods The Trauma Quality Improvement Program (2014–2016) was queried for adolescent trauma patients aged 
13–17 years. Adolescent smokers were 1:2 propensity-score-matched to non-smokers based on age, comorbidities, and 
injury type. Data were analyzed using chi square for categorical data and Mann–Whitney U test for continuous data.
Results From 32,610 adolescent patients, 997 (3.1%) were smokers. After matching, 459 smokers were compared to 918 
non-smokers. There were no differences in matched characteristics. Compared to non-smokers, smokers had an increased 
rate of pneumonia (3.1% vs. 1.1%, p = 0.01) but not ARDS (0.2% vs. 0%, p = 0.16). Compared to the non-smoking group, 
the smokers had a longer median total hospital length-of-stay (3 vs. 2 days, p = 0.01) and no difference in overall mortality 
(1.5% vs. 2.4%, p = 0.29).
Conclusion Smoking is associated with an increased rate of pneumonia in adolescent trauma patients. Future research should 
target smoking cessation and/or interventions to mitigate the deleterious effects of smoking in this population.
Keywords Pediatric · Smokers · Trauma surgery · ARDS · Pneumonia · TQIP
Introduction
Tobacco consumption is currently the leading cause of pre-
ventable death worldwide, claiming approximately 5 million 
lives every year since 1990 [1, 2]. Although cigarette use 
among the youth has been declining since 2011, more than 
300 adolescents each day become daily cigarette smokers in 
the United States [3]. Teenagers who smoke cigarettes are 
more likely to use other substances (i.e., alcohol and mari-
juana) and be involved in risky behaviors, such as violence, 
theft, and suicide [4, 5]; this behavior increases the risk of 
being involved in trauma [6].
There are over 7000 chemicals in tobacco smoke [7]. 
Acrolein, one of the cigarette’s many carcinogens, has been 
demonstrated to increase lung vascular permeability by 
disrupting adherens junctions and actin fibers [8, 9]. Other 
chemicals in cigarette smoke are known to cause cellular 
insult, which increases the risk of bacterial pneumonia [10, 
11]. Additionally, cigarette smoking causes an increase in 
reactive oxygen species and decreases surfactant produc-
tion, both of which are underlying pathophysiological 
mechanisms of acute respiratory distress syndrome (ARDS) 
[12–17]. Approximately 200,000 patients in the United 
States develop ARDS each year, with up to 4.4% occurring 
in trauma patients [18, 19]. One retrospective cohort study 
suggested that 50% of ARDS cases were associated with 
cigarette smoking [20]. Similarly, a prospective study on 
blunt trauma patients found that cigarette smoking increased 
platelet aggregation and was associated with an increased 
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risk of ARDS [21]. Additionally, there are studies that link 
smoking to the development of pneumonia [22, 23], and 
many studies show a high incidence of pneumonia in trauma 
patients [24–27]. However, to our knowledge, there are no 
studies evaluating the rate of pneumonia and ARDS in ado-
lescent trauma smokers. We hypothesized that adolescent 
smokers with traumatic injury have a higher rate of ARDS 
and pneumonia compared to non-smokers. In addition, we 
also sought to provide a descriptive analysis of adolescent 
smokers involved in trauma.
Methods
This study was approved by the Institutional Review Board 
at the University of California, Irvine. A retrospective analy-
sis of the Pediatric Trauma Quality Improvement Program 
(TQIP) was performed between 2014 and 2016 to identify 
adolescent trauma patients between the ages of 13 and 17. 
Patients who were current smokers were compared to non-
smokers. This is listed as one of the 30-required comorbidi-
ties to be reported in TQIP and is defined by “A patient who 
reports smoking cigarettes every day or some days within the 
last 12 months. This excludes patients who smoke cigars or 
pipes or use smokeless tobacco (chewing tobacco or snuff)”.
The primary outcomes were the development of ARDS 
or pneumonia. Other measured outcomes included total hos-
pital length of stay (LOS), intensive care unit (ICU) LOS, 
ventilator days, in-hospital mortality, and other in-hospital 
complications including cardiac arrest, acute kidney injury 
(AKI), decubitus ulcer, deep site infection, compartment 
syndrome, deep vein thrombosis (DVT), pulmonary embo-
lism, and cerebrovascular accident.
Frequency statistics were performed for all groups. 
A Mann–Whitney U test was used to compare continu-
ous variables and chi-square was used to compare cat-
egorical variables for bivariate analysis. Categorical data 
were reported as percentages, and continuous data were 
reported as medians with interquartile range or as means 
with standard deviations. Due to the observed imbalance 
in the sample size between the two groups, smokers were 
matched with non-smokers using a 1:2 propensity score 
model based on age, gender, hypotension on admission 
(systolic blood pressure < 90 mmHg), injury severity score 
(ISS), as well as injuries to the brain, spine, upper and lower 
extremity, lung, heart, stomach, small intestine, colorectal, 
pancreas, liver, spleen, and kidney. Injuries were defined 
by appropriate international-classification of diseases ver-
sion-9 (ICD-9) diagnosis codes. We included in our analysis 
only those cases that were within 0.001 of the estimated 
logit. This technique of defining the closeness of a matched 
case is termed caliper matching and is a validated method 
of emulating randomization in observational studies [28]. 
Once propensity scores were calculated for each case, one 
smoker and two non-smoking-matched patients were identi-
fied from the sample. If a patient that smoked did not have a 
close match available, they were excluded from any further 
analysis. All p values were two sided, with a statistical sig-
nificance level of < 0.05. All analyses were performed with 
IBM SPSS Statistics for Windows (Version 24, IBM Corp., 
Armonk, NY).
Results
Demographics and injury types
From 32,610 adolescent trauma patients, 997 (3.1%) were 
smokers. Of the smokers, 759 (76.1%) were male with a 
median age of 17 years and a median ISS of 9. After pro-
pensity matching, 459 smokers were compared to 918 non-
smokers. There were 538 patients who did not fit into our 
propensity-matched model, and thus, were excluded from the 
analysis. There were no differences among the smokers and 
non-smokers with respect to median age (16 vs. 16 years, 
p = 0.99), male gender (75.6% vs. 73.7%, p = 0.51), hypoten-
sion on admission (1.3% vs. 1.9%, p = 0.46), and median ISS 
(9 vs. 9, p = 0.20) (Table 1). The injury profile was similar 
Table 1  Demographics of adolescent trauma patients stratified by smoking status
ISS injury severity score, IQR interquartile range, COPD chronic obstructive pulmonary disease
Characteristic All smokers (n = 997) Non-smokers (n = 918) Smokers (n = 459) p value
Age, year, median (IQR) 17.0 (16, 17) 16.0 (16, 17) 16.0 (16, 17) 0.99
Male, n (%) 759 (76.1%) 677 (73.7%) 346 (75.4%) 0.51
ISS, median (IQR) 9.0 (6, 12) 9 (5, 12) 9 (5, 13) 0.20
Hypotensive on admission, n (%) 14 (1.4%) 17 (1.9%) 6 (1.3%) 0.46
Comorbidities, n (%)
 Diabetes 3 (0.3%) 0 1 (0.2%) 0.16
 Hypertension 4 (0.4%) 2 (0.2%) 2 (0.4%) 0.48
 COPD 19 (1.9%) 15 (1.6%) 12 (2.6%) 0.22
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for both groups, with most patients sustaining blunt trauma 
(86.1% vs. 89.2%, p = 0.10), and presenting with a traumatic 
brain injury (38.6% vs. 39.0%, p = 0.88) (Table 2).
Primary outcomes and hospital outcomes/
complications
Compared to non-smokers, smokers had an increased rate of 
pneumonia (3.1% vs. 1.1%, p = 0.01). There was no differ-
ence in the rate of all other in-hospital complications includ-
ing ARDS (0.2% vs. 0%, p = 0.16), DVT (0.2% vs. 1.0%, 
p = 0.12), and AKI (0% vs. 0.1%, p = 0.48).
Smokers had a longer median hospital LOS (3 vs. 2 days, 
p = 0.01) compared to non-smokers. There was no differ-
ence in mortality (1.5% vs. 2.4%, p = 0.29), ICU LOS (3 vs. 
2 days, p = 0.55), or ventilator days (3 vs. 2 days, p = 0.75) 
between the two groups (Table 3).
Discussion
While there is existing literature on the effects of smoking on 
adult trauma patient outcomes, to our knowledge, this is the 
first study to evaluate the effects of smoking on outcomes in 
the adolescent trauma patient population. Our retrospective 
analysis reported that 3.1% of adolescent trauma patients 
were cigarette smokers. Compared to non-smoking trauma 
patients, smokers were more likely to develop pneumonia 
and have longer LOS, but there was no difference between 
the groups with respect to mortality or ARDS, the latter 
being an extremely rare complication in this population.
Cigarette smoking impedes the lung’s healing ability and 
predisposes it to injury following an inciting event. Previous 
studies on adult smokers have demonstrated increased rates 
of ARDS secondary to lung injury when compared to non-
smokers in both critically ill and trauma patients [21, 29–32]. 
In a study of 74 patients by Panzer et al., critically ill adult 
trauma smokers had an altered respiratory bacterial com-
munity including enrichment of Enterobacteriaceae associ-
ated with an increased incidence of ARDS [29]. There is a 
progressive increase in incidence of ARDS following trauma 
with increasing age, with a peak incidence in patients aged 
60–69 years [33]. Our results demonstrated a low incidence 
(0.3%) of ARDS in the adolescent trauma population, with 
all cases occurring in smokers; however, this was not sta-
tistically significant in comparison to the non-smokers. Our 
findings are consistent with other pediatric studies, which 
report a low incidence of ARDS in non-trauma patients. Fur-
thermore, the rate of ARDS has previously been shown to 
be low specifically in pediatric trauma patients with Roulet 
et al. finding an incidence of 0.5% of all pediatric trauma 
admissions and Killen et al. demonstrating an incidence of 
1.8% of all pediatric patients admitted to an ICU [34, 35]. 
Lee et al. postulated the lower rate of ARDS and associated 
mortality in younger patients is due to greater capacity for 
repair, and altered cytokine burden including interleukin-1 
and -8, and tissue necrosis factor alpha [36]. In addition, 
there is also likely a dose/duration association with smok-
ing that may have not reached a critical threshold for these 
adolescents [37]. Future investigations regarding the patho-
physiology that protects adolescents from developing ARDS 
appears warranted.
Smoking increases the risk of inflammatory and infec-
tious complications in trauma patients. Bagaitkar et  al. 
demonstrated that adult patients who smoke cigarettes have 
a 2.6-fold increased risk of developing pneumonia [22]. 
Table 2  Injury type in 
adolescent trauma patients 
stratified by smoking status
TBI traumatic brain injury
Injury type, n (%) All smokers (n = 997) Non-smoker (n = 918) Smoker (n = 459) p value
Blunt trauma 871 (87.4%) 794 (89.2%) 384 (86.1%) 0.10
TBI 238 (23.9%) 358 (39.0%) 177 (38.6%) 0.88
Spine 125 (12.5%) 163 (17.8%) 83 (18.1%) 0.88
Upper extremity 139 (13.9%) 177 (19.3%) 98 (21.4%) 0.37
Lower extremity 132 (13.2%) 170 (18.5%) 96 (20.9%) 0.29
Esophagus 0 1 (0.1%) 0 0.48
Colorectal 13 (1.3%) 12 (1.3%) 6 (1.3%) 1.00
Pancreas 2 (0.2%) 1 (0.1%) 1 (0.2%) 0.62
Stomach 6 (0.6%) 1 (0.1%) 0 0.48
Liver 35 (3.5%) 42 (4.6%) 15 (3.3%) 0.25
Small intestine 14 (1.4%) 9 (1.0%) 8 (1.7%) 0.23
Spleen 33 (3.3%) 32 (3.5%) 22 (4.8%) 0.24
Kidney 25 (2.5%) 21 (2.3%) 10 (2.2%) 0.90
Lung 137 (13.7%) 145 (15.8%) 73 (15.9%) 0.96
Heart 2 (0.2%) 2 (0.2%) 2 (0.4%) 0.48
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However, Ferro et al.’s retrospective analysis of adult trauma 
patients demonstrated no difference in the rate of pneumonia 
in smokers compared to non-smokers [38]. Our data are the 
first to suggest an increased incidence of pneumonia in ado-
lescent trauma patients who smoke. One explanation for the 
difference in results is that unlike the study by Ferro et al., 
we propensity-matched smokers to similar non-smokers 
based on comorbidities and injuries. In addition to the mor-
bidity associated with pneumonia, treatment costs $6042 on 
average for younger patients with the majority of the cost 
due to the hospital LOS [39, 40]. Our data corroborate this 
finding as adolescent smoking trauma patients were dem-
onstrated to have a longer LOS. While there is certainly a 
dose–response increase in respiratory complications caused 
by cigarette smoking, this study demonstrates an increased 
rate of pneumonia and hospital LOS despite only minimal 
cumulative exposure. Our results suggest there is no safe 
smoking age, and by understanding this risk, clinicians can 
counsel their adolescent patients on the dangers of both 
short- and long-term cigarette smoking.
Trauma patients who smoke do not consistently have 
worse outcomes compared to non-smokers [41]. In fact, 
several studies have demonstrated a lower mortality in adult 
smokers following a traumatic injury [38, 42, 43]. This phe-
nomenon is termed the “smoker’s paradox,” and was origi-
nally described in adult patients who sustained acute myo-
cardial infarction [44–46]. One proposed mechanism is that 
smoking increases coagulability, which may be beneficial 
during an acute hemorrhagic injury [47]. Another possi-
ble mechanism is that exposure to cigarette smoke causes 
adaptation to hypoxemia such that periods of acute ischemia 
associated with hemorrhagic shock from trauma have less of 
a deleterious effect [48]. There are currently no studies dem-
onstrating the “smoker’s paradox” in the adolescent popula-
tion regardless of the disease process. Our data demonstrated 
that smoking had no effect on risk of survival in adolescent 
trauma patients. In fact, the only two complications that 
were increased in this population were pneumonia and an 
unplanned return to the operating room. This may suggest 
that the protective mechanism of cigarette smoking has not 
yet developed in adolescent smokers who likely have not 
smoked for as long as adults who exhibit the smoker’s para-
dox. Future combined clinical and basic science research to 
evaluate this is needed.
Table 3  Clinical outcomes 
in adolescent trauma patients 
stratified by smoking status
LOS length of stay, IQR interquartile range, OR operating room, ICU intensive care unit, CRBSI catheter-
related bloodstream infection
Outcome All smokers (n = 997) Non-
smokers 
(n = 918)
Smokers (n = 459) p value
LOS, days, median (IQR) 3.0 (2, 4) 2.0 (2, 4) 3.0 (2, 5) 0.01
ICU, days, median (IQR) 3.0 (1, 4) 2.0 (1, 4) 3.0 (2, 5) 0.55
Ventilator, days, median (IQR) 2.0 (1, 4) 2.0 (1, 4) 3.0 (1, 10.5) 0.75
Complications, n (%)
 Unplanned ICU, n (%) 7 (0.7%) 8 (0.9%) 3 (0.7%) 0.67
 Unplanned intubation, n (%) 2 (0.2%) 2.0 (0.2%) 1.0 (0.2%) 1.00
 Unplanned return to OR, n (%) 6 (0.6%) 3.0 (0.3%) 6.0 (1.3%) 0.03
 Acute respiratory distress syndrome 3 (0.3%) 0 1 (0.2%) 0.16
 Acute kidney injury 2 (0.2%) 1 (0.1%) 0 0.48
 Cardiac arrest 2 (0.2%) 4 (0.4%) 1 (0.2%) 0.53
 Decubitus ulcer 2 (0.2%) 3 (0.3%) 1 (0.2%) 0.72
 Deep site infection 2 (0.2%) 1 (0.1%) 1 (0.2%) 0.62
 Compartment syndrome 1 (0.1%) 0 1 (0.2%) 0.16
 Deep vein thrombosis 4 (0.4%) 9 (1.0%) 1 (0.2%) 0.12
 Graft failure 2 (0.2%) 2 (0.2%) 2 (0.4%) 0.48
 Pneumonia 14 (1.4%) 10 (1.1%) 14 (3.1%) 0.01
 Pulmonary embolism 0 1 (0.1%) 0 0.48
 Cerebrovascular accident 2 (0.2%) 1 (0.1%) 1 (0.2%) 0.62
 Superficial infection 4 (0.4%) 1 (0.1%) 3 (0.7%) 0.08
 Urinary tract infection 2 (0.2%) 2 (0.2%) 2 (0.4%) 0.48
 CRBSI 0 1 (0.1%) 0 0.48
 Severe sepsis 1 (0.1%) 1 (0.1%) 0 0.48
 Other 66 (6.6%) 78 (8.5%) 33 (7.2%) 0.40
Mortality, n (%) 9 (0.9%) 22 (2.4%) 7 (1.5%) 0.29
747Pediatric Surgery International (2020) 36:743–749 
1 3
As a large retrospective database study, there are inher-
ent limitations including reporting bias, coding errors, and 
missing data. A significant limitation is that 538 patients 
did not fit into our propensity-matched model and thus, 
were excluded from the analysis. Alternatively, we could 
have decreased the number of controls we utilized in our 
propensity matching; however, this may have resulted in a 
biased matching system. Furthermore, there was no differ-
ence in baseline characteristics and outcomes in the total 
smokers compared to the smokers we utilized after propen-
sity matching. In addition, missing pertinent data variables 
include the timing of pneumonia and whether it was com-
munity acquired or nosocomial, the bacterial pathogen, and 
means of diagnosis of pneumonia (i.e., clinical vs. culture). 
Urine markers indicating recent cigarette smoke exposure, as 
well as pulmonary functional status (i.e., baseline incentive 
spirometer or pulmonary function testing) are not available 
within the TQIP database. Also, given that smoking is a self-
reported variable, it is highly likely the incidence is signifi-
cantly underreported, especially in an adolescent population 
that may be apprehensive to disclose illegal conduct. In addi-
tion, limitations of the database include the lack of granu-
larity regarding the smoking history including the number 
of cigarettes smoked daily as well as how many years of 
smoking previously occurred. Although the non-smoking 
group had not smoked within the past 12 months, the per-
centage of ex-smokers in this group is not available within 
the database. Finally, there are no data within TQIP regard-
ing other forms of smoking such as vaping. Despite these 
limitations, we are the first to evaluate adolescent smokers 
using a large trauma database and our study is strengthened 
by its generalizability.
Conclusion
In this 3-year review of the TQIP database, 3.1% of adoles-
cent trauma patients were found to be smokers. In support of 
our hypothesis, there was nearly triple the rate of pneumonia 
among the smokers, compared to propensity-matched non-
smokers. However, there was no difference in the rate of 
ARDS with only three cases of an adolescent trauma patient 
developing this complication. Future research is needed to 
target this at-risk adolescent trauma population for smoking 
cessation counseling to help decrease the risk of pneumo-
nia and reduce hospital costs. In addition, trauma providers 
should be aware of the significantly increased rate of pneu-
monia in this population to either mitigate the risk or diag-
nose and treat this population early in the hopes of reducing 
associated morbidity like the increased LOS observed in 
this study.
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